Literature DB >> 11427253

Modifying the cellular transport of DNA-based vaccines alters the immune response to hantavirus nucleocapsid protein.

G Bucht1, K B Sjölander, S Eriksson, L Lindgren, F Elgh.   

Abstract

Puumala virus is a member of the hantavirus genus (family Bunyaviridae) and is one of the causative agents of hemorrhagic fever with renal syndrome (HFRS) in Europe. A genetic vaccination approach was conducted to investigate if the immune response could be modulated using different cellular secretion and/or localisation signals, and the immune responses were analysed in BALB/c mice and in a bank vole infectious model. Rodents vaccinated with DNA constructs encoding the antigen fused to an amino-terminal secretion signal raised significantly higher antibody levels when compared to using constructs lacking secretion signals. Furthermore, the ratios of the IgG subclasses (IgG2a/IgG1) were raised by the use of cellular localisation signals, indicating a more pronounced Th1-type of immune response. The majority of the mice, or bank voles, immunised with DNA encoding a secreted form of the antigen showed a positive lymphoproliferative response and were protected against challenge with Puumala virus (strain Kazan-wt).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427253     DOI: 10.1016/s0264-410x(01)00151-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

Review 1.  Nucleic acid vaccines: tasks and tactics.

Authors:  B S McKenzie; A J Corbett; J L Brady; C M Dyer; R A Strugnell; S J Kent; D R Kramer; J S Boyle; A M Lew
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Treatment of hantavirus pulmonary syndrome.

Authors:  Colleen B Jonsson; Jay Hooper; Gregory Mertz
Journal:  Antiviral Res       Date:  2007-11-21       Impact factor: 5.970

3.  Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses.

Authors:  Cristina de Carvalho Nicacio; Marcelo Gonzalez Della Valle; Paula Padula; Ewa Björling; Alexander Plyusnin; Ake Lundkvist
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs.

Authors:  Nina Lagerqvist; Jonas Näslund; Ake Lundkvist; Michèle Bouloy; Clas Ahlm; Göran Bucht
Journal:  Virol J       Date:  2009-01-17       Impact factor: 4.099

5.  Genetic immunization with Hantavirus vaccine combining expression of G2 glycoprotein and fused interleukin-2.

Authors:  Huang Hao; Li Xiu; Zhang Zehua; Jia Min; Hu Hongbo; Wu Zhihong; Zhu Zhenhua; Wan Xiaohong; Huang Hanju
Journal:  Genet Vaccines Ther       Date:  2008-10-22

Review 6.  Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses.

Authors:  Joseph W Golden; Christopher D Hammerbeck; Eric M Mucker; Rebecca L Brocato
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411

Review 7.  Vaccines and Therapeutics Against Hantaviruses.

Authors:  Rongrong Liu; Hongwei Ma; Jiayi Shu; Qiang Zhang; Mingwei Han; Ziyu Liu; Xia Jin; Fanglin Zhang; Xingan Wu
Journal:  Front Microbiol       Date:  2020-01-30       Impact factor: 5.640

Review 8.  The Immune Correlates of Orthohantavirus Vaccine.

Authors:  Joon-Yong Bae; Jin Il Kim; Mee Sook Park; Gee Eun Lee; Heedo Park; Ki-Joon Song; Man-Seong Park
Journal:  Vaccines (Basel)       Date:  2021-05-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.